BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21853157)

  • 61. Role of phosphatidylinositol-3 kinase and its association with Gab1 in thrombopoietin-mediated up-regulation of platelet function.
    Kojima H; Shinagawa A; Shimizu S; Kanada H; Hibi M; Hirano T; Nagasawa T
    Exp Hematol; 2001 May; 29(5):616-22. PubMed ID: 11376875
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Thrombopoietin and interleukin 11 have different modulatory effects on cell cycle and programmed cell death in primary acute myeloid leukemia cells.
    Tafuri A; Lemoli RM; Petrucci MT; Ricciardi MR; Fogli M; Bonsi L; Ariola C; Strippoli P; Gregorj C; Petti MC; Tura S; Mandelli F; Bagnara GP
    Exp Hematol; 1999 Aug; 27(8):1255-63. PubMed ID: 10428502
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Signal transduction by the receptors for thrombopoietin (c-mpL) and interleukin-3 in hematopoietic and nonhematopoietic cells.
    Morella KK; Bruno E; Kumaki S; Lai CF; Fu J; Wang HM; Murray L; Hoffman R; Timour M; Bénit L
    Blood; 1995 Jul; 86(2):557-71. PubMed ID: 7605989
    [TBL] [Abstract][Full Text] [Related]  

  • 64. TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations.
    Pardanani A; Hood J; Lasho T; Levine RL; Martin MB; Noronha G; Finke C; Mak CC; Mesa R; Zhu H; Soll R; Gilliland DG; Tefferi A
    Leukemia; 2007 Aug; 21(8):1658-68. PubMed ID: 17541402
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Developmental expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation.
    Madoiwa S; Komatsu N; Mimuro J; Kimura K; Matsuda M; Sakata Y
    Blood; 1999 Jul; 94(2):475-82. PubMed ID: 10397715
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Thrombopoietin induces histidine decarboxylase gene expression in c-mpl transfected UT7 cells.
    Pacilio M; Debili N; Arnould A; Machavoine F; Rolli-Derkinderen M; Bodger M; Arock M; Duménil D; Dy M; Schneider E
    Biochem Biophys Res Commun; 2001 Aug; 285(5):1095-101. PubMed ID: 11478766
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Thrombopoietin (TPO) induces c-myc expression through a PI3K- and MAPK-dependent pathway that is not mediated by Akt, PKCzeta or mTOR in TPO-dependent cell lines and primary megakaryocytes.
    Chanprasert S; Geddis AE; Barroga C; Fox NE; Kaushansky K
    Cell Signal; 2006 Aug; 18(8):1212-8. PubMed ID: 16380230
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.
    Sattler M; Durstin MA; Frank DA; Okuda K; Kaushansky K; Salgia R; Griffin JD
    Exp Hematol; 1995 Aug; 23(9):1040-8. PubMed ID: 7543416
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Thrombopoietin is synergistic with other cytokines for expansion of cord blood progenitor cells.
    Won JH; Cho SD; Park SK; Lee GT; Baick SH; Suh WS; Hong DS; Park HS
    J Hematother Stem Cell Res; 2000 Aug; 9(4):465-73. PubMed ID: 10982244
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells.
    Cook AM; Li L; Ho Y; Lin A; Li L; Stein A; Forman S; Perrotti D; Jove R; Bhatia R
    Blood; 2014 May; 123(18):2826-37. PubMed ID: 24668492
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lnk regulates integrin alphaIIbbeta3 outside-in signaling in mouse platelets, leading to stabilization of thrombus development in vivo.
    Takizawa H; Nishimura S; Takayama N; Oda A; Nishikii H; Morita Y; Kakinuma S; Yamazaki S; Okamura S; Tamura N; Goto S; Sawaguchi A; Manabe I; Takatsu K; Nakauchi H; Takaki S; Eto K
    J Clin Invest; 2010 Jan; 120(1):179-90. PubMed ID: 20038804
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification and characterization of an alternative splice variant of Mpl with a high affinity for TPO and its activation of ERK1/2 signaling.
    Wang Q; Sun R; Wu L; Huang J; Wang P; Yuan H; Qiu F; Xu X; Wu D; Yu Y; Liu X; Zhang Q
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2852-63. PubMed ID: 24144576
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Human thrombopoietin reduces myocardial infarct size, apoptosis, and stunning following ischaemia/reperfusion in rats.
    Baker JE; Su J; Hsu A; Shi Y; Zhao M; Strande JL; Fu X; Xu H; Eis A; Komorowski R; Jensen ES; Tweddell JS; Rafiee P; Gross GJ
    Cardiovasc Res; 2008 Jan; 77(1):44-53. PubMed ID: 18006466
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Thrombopoietin regulates proliferation, apoptosis, secretory activity and intracellular messengers in porcine ovarian follicular cells: involvement of protein kinase A.
    Sirotkin AV; Sanislo P; Schaeffer HJ; Florkovicová I; Kotwica J; Bulla J; Hetényi L
    J Endocrinol; 2004 Dec; 183(3):595-604. PubMed ID: 15590985
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of a cytokine combination including thrombopoietin for improved transduction of a retroviral gene into G-CSF-mobilized CD34+ human blood cells.
    Kim HJ; Okamoto Y; Ito M; Takaue Y; Kawano Y; Watanabe T; Yamaue T; Tohda Y; Ogose T; Shimada T; Shimosaka A; Kuroda Y
    Stem Cells; 1997; 15(5):347-52. PubMed ID: 9323796
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cytokine-mediated erythroid maturation in megakaryoblastic human cell line HU-3.
    Morgan DA; Class R; Soslau G; Brodsky I
    Exp Hematol; 1997 Dec; 25(13):1378-85. PubMed ID: 9406997
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adaptor protein Lnk binds to PDGF receptor and inhibits PDGF-dependent signaling.
    Gueller S; Hehn S; Nowak V; Gery S; Serve H; Brandts CH; Koeffler HP
    Exp Hematol; 2011 May; 39(5):591-600. PubMed ID: 21310211
    [TBL] [Abstract][Full Text] [Related]  

  • 78. LNK suppresses interferon signaling in melanoma.
    Ding LW; Sun QY; Edwards JJ; Fernández LT; Ran XB; Zhou SQ; Scolyer RA; Wilmott JS; Thompson JF; Doan N; Said JW; Venkatachalam N; Xiao JF; Loh XY; Pein M; Xu L; Mullins DW; Yang H; Lin DC; Koeffler HP
    Nat Commun; 2019 May; 10(1):2230. PubMed ID: 31110180
    [TBL] [Abstract][Full Text] [Related]  

  • 79. JAK2 tyrosine kinase inhibitor AG490 suppresses cell growth and invasion of gallbladder cancer cells via inhibition of JAK2/STAT3 signaling.
    Fu LX; Lian QW; Pan JD; Xu ZL; Zhou TM; Ye B
    J Biol Regul Homeost Agents; 2017; 31(1):51-58. PubMed ID: 28337870
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tyrosine phosphorylation and activation of JAK family tyrosine kinases by interleukin-9 in MO7E cells.
    Yin T; Yang L; Yang YC
    Blood; 1995 Jun; 85(11):3101-6. PubMed ID: 7756643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.